Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry

SIMPLE SUMMARY: Approximately 30–50% of colorectal cancer patients will develop colorectal liver metastases (CRLM) in the course of their disease. Though partial hepatectomy is considered the historical gold standard, complete removal of all metastases is only feasible in 20–30% of patients. Thermal...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieuwenhuizen, Sanne, Dijkstra, Madelon, Puijk, Robbert S., Timmer, Florentine E. F., Nota, Irene M., Opperman, Jip, van den Bemd, Bente, Geboers, Bart, Ruarus, Alette H., Schouten, Evelien A. C., de Vries, Jan J. J., Scheffer, Hester J., van Geel, Anne M., van Waesberghe, Jan Hein T. M., Swijnenburg, Rutger-Jan, Versteeg, Kathelijn S., Lissenberg-Witte, Birgit I., van den Tol, M. Petrousjka, Haasbeek, Cornelis J. A., Meijerink, Martijn R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428373/
https://www.ncbi.nlm.nih.gov/pubmed/34503113
http://dx.doi.org/10.3390/cancers13174303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428373/
https://www.ncbi.nlm.nih.gov/pubmed/34503113
http://dx.doi.org/10.3390/cancers13174303

Ejemplares similares